EP3429693
NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.3.2017EP published:
23.8.2023EP application number:
17713127.3
EPO information:
European Patent Register
Max expiry date:
12.3.2037
Title in English:
NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
13.3.2017EP application
23.8.2023EP Publication
Owner
Name:
Mersana Therapeutics, Inc.Address:
840 Memorial Drive, Cambridge, MA 02139, US
Inventor
Name:
BERGSTROM, Donald, A.Address:
Winchester MA 01890, US
Name:
BODYAK, Natalya, D.Address:
Boston MA 02135, US
Name:
LOWINGER, Timothy, B.Address:
Carlisle MA 01741, US
Name:
PARK, Peter, U.Address:
Lincoln MA 01773, US
Name:
POLING, Laura, L.Address:
Acton MA 01720, US
Name:
YURKOVETSKIY, Aleksandr, V.Address:
Littleton MA 01460, US
Priority
Number:
201662308567 PDate:
15.3.2016Country:
US
Number:
201662323068 PDate:
15.4.2016Country:
US
Number:
201662383324 PDate:
2.9.2016Country:
US
Classification
Categories:
A61K 47/68, A61P 35/00, A61K 47/59